Key facts
- NYX-Medico’s last known valuation is $2.4M (May 2025).
- It has raised $80K; the latest was Angel (individual) ($80K) in May 2025.
- Notable investors include Keystones (Denmark).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for NYX-Medico
- ·The full record, as it builds
Funding rounds
No funding rounds for NYX-Medico are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NYX-Medico
Developer of health-enhancing wellness products designed for natural sleep support and improved breathing. The company combines scientifically backed formulations with natural ingredients, enabling individuals to overcome sleep-related challenges and enhance daily performance through optimized rest and relaxation.
- Sector
- Healthcare
- HQ
- Virum, Denmark
- Founded
- 2023
- Employees
- 1
- Website
- nyx-medico.com/
- Ownership
- Privately Held (backing)
NYX-Medico doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NYX-Medico shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NYX-Medico in its N-PORT filings yet. We sweep new filings monthly.